Stacy L. Moulder

Neoadjuvant Pertuzumab‐containing Regimens Improve Pathologic Complete Response Rates in Stage II to III HER‐2/neu‐positive Breast Cancer: A Retrospective, Single Institution Experience

Takeo Fujii, Kenneth R. Hess, Elizabeth A. Mittendorf, 2018, Clinical breast cancer.

Challenges and perspective of drug repurposing strategies in early phase clinical trials

Funda Meric-Bernstam, Razelle Kurzrock, Naoto T. Ueno, 2015, Oncoscience.

PIK3CA Mutations in Advanced Cancers: Characteristics and Outcomes

Razelle Kurzrock, David S. Hong, Rajyalakshmi Luthra, 2012, Oncotarget.

PIK3CA Mutations in Patients with Advanced Cancers Treated with PI3K/AKT/mTOR Axis Inhibitors

Razelle Kurzrock, David S. Hong, Rajyalakshmi Luthra, 2011, Molecular Cancer Therapeutics.

Multiple gene aberrations and breast cancer: lessons from super-responders

Razelle Kurzrock, Philip J. Stephens, Roman Yelensky, 2015, BMC Cancer.